Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 3,700,000 shares, an increase of 6.9% from the November 30th total of 3,460,000 shares. Based on an average daily trading volume, of 1,300,000 shares, the short-interest ratio is presently 2.8 days.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on the stock. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James boosted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $554.17.
Check Out Our Latest Research Report on ISRG
Insider Buying and Selling
Institutional Investors Weigh In On Intuitive Surgical
Hedge funds and other institutional investors have recently bought and sold shares of the company. Mirador Capital Partners LP raised its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Exome Asset Management LLC increased its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the last quarter. Consolidated Planning Corp boosted its stake in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Finally, Swiss National Bank increased its position in shares of Intuitive Surgical by 0.3% in the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Stock Down 0.9 %
Shares of NASDAQ ISRG opened at $521.96 on Thursday. Intuitive Surgical has a twelve month low of $320.26 and a twelve month high of $556.23. The company’s fifty day moving average is $532.03 and its 200-day moving average is $489.68. The stock has a market cap of $185.91 billion, a price-to-earnings ratio of 83.92, a P/E/G ratio of 5.31 and a beta of 1.38.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current fiscal year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Work and Play: Investing in the Rise of Bleisure Travel
- How to Evaluate a Stock Before Buying
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- What is the FTSE 100 index?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.